Skip to content

Performance Evaluation of Blood Glucose Monitoring System Using ISO Study Design

Performance Evaluation of the Contour TS BGMS Using ISO/DIS 15197:2011 Section 8 Study Design and Performance Criteria

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01575080
Enrollment
102
Registered
2012-04-11
Start date
2012-04-30
Completion date
2012-04-30
Last updated
2016-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The purpose of this study is to determine if untrained subjects who have diabetes can operate the Blood Glucose Monitoring System (BGMS) and obtain acceptable glucose results.

Interventions

DEVICEContour TS Blood Glucose Monitoring System

Untrained subjects with diabetes perform self Blood Glucose (BG) tests with capillary fingerstick blood and AST of the palm and forearm using the Contour TS Blood Glucose Monitoring System. All BG results are compared to a reference laboratory glucose method.

Sponsors

Ascensia Diabetes Care
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have a diagnosis of diabetes * Be 18 years of age or older * Be able to speak, read and understand English and understand the Informed Consent document. * Be willing to complete study procedures

Exclusion criteria

* Pregnancy * Infections or skin disorders at the puncture site (at the discretion of the site professional staff). * Hemophilia, bleeding disorder, or clotting problems. Persons taking aspirin (81 mg or 325 mg) daily or Plavix® are not reason for exclusion. * Physical (dexterity), visual, or neurological impairments that would make the person unable to perform testing with the BGM (at the discretion of the site professional staff). * A condition, in the opinion of the Investigator, would put the subject at risk or influence the conduct of the study or interpretation of the results. The reason for exclusion will be documented by the professional staff. * Previously participated in a blood glucose monitoring study using Contour TS system or use the Contour TS for personal use when monitoring blood glucose. * Working for a competitive medical device company or having an immediate family member or someone who is not a family member but is living within the household of someone who works for such a company * Working for a medical laboratory, hospital or other clinical setting that involves training on and clinical use of blood glucose monitors

Design outcomes

Primary

MeasureTime frameDescription
Number of Self-Test Fingerstick Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method1 hourUntrained subjects with diabetes self-test fingerstick blood using the Blood Glucose Monitoring System (BGMS). BGMS results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI Analyzer BG results are used to calculate the number of BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma).

Secondary

MeasureTime frameDescription
Number of Self-Test Alternative Site (Palm) Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method1 hourUntrained subjects with diabetes self-test Alternative Site (AST) Palm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST palm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST palm BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma).
Number of Self-Test Alternative Site (Forearm) Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method1 hourUntrained subjects with diabetes self-test Alternative Site (AST) Forearm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST forearm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST forearm BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma).
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements1 hourSubjects will complete short questionnaires to provide feedback on the labeling materials and system ease of use. Subjects may respond 'Strongly Agree' 'Agree' 'Neutral' 'Disagree' 'Strongly Disagree'.

Countries

United States

Participant flow

Participants by arm

ArmCount
Intended Users of the Monitoring System
Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.
102
Total102

Baseline characteristics

CharacteristicIntended Users of the Monitoring System
Age, Continuous55 years
Region of Enrollment
United States
102 participants
Sex: Female, Male
Female
53 Participants
Sex: Female, Male
Male
49 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
2 / 102
serious
Total, serious adverse events
0 / 102

Outcome results

Primary

Number of Self-Test Fingerstick Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method

Untrained subjects with diabetes self-test fingerstick blood using the Blood Glucose Monitoring System (BGMS). BGMS results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI Analyzer BG results are used to calculate the number of BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma).

Time frame: 1 hour

Population: 102 untrained subjects tested one test strip lot on the Contour TS Blood Glucose Monitoring System.

ArmMeasureValue (NUMBER)
Intended Users of the Monitoring SystemNumber of Self-Test Fingerstick Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method84 Number of BG Test Results
Secondary

Number of Self-Test Alternative Site (Forearm) Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method

Untrained subjects with diabetes self-test Alternative Site (AST) Forearm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST forearm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST forearm BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma).

Time frame: 1 hour

Population: 102 untrained subjects tested one test strip lot using the Contour TS BG Monitoring System. One subject was unable to obtain sufficient sample volume to test. Another subject's meter displayed

ArmMeasureValue (NUMBER)
Intended Users of the Monitoring SystemNumber of Self-Test Alternative Site (Forearm) Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method83 Number of BG Test Results
Secondary

Number of Self-Test Alternative Site (Palm) Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method

Untrained subjects with diabetes self-test Alternative Site (AST) Palm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST palm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST palm BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma).

Time frame: 1 hour

Population: 102 untrained subjects tested one test strip lot on the Contour TS Blood Glucose Monitoring System

ArmMeasureValue (NUMBER)
Intended Users of the Monitoring SystemNumber of Self-Test Alternative Site (Palm) Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method78 Number of BG Test Results
Secondary

Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements

Subjects will complete short questionnaires to provide feedback on the labeling materials and system ease of use. Subjects may respond 'Strongly Agree' 'Agree' 'Neutral' 'Disagree' 'Strongly Disagree'.

Time frame: 1 hour

ArmMeasureGroupValue (NUMBER)
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsI found it easy to do a blood test w this meter98 participants
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsMeter display (test result) is easy to read102 participants
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsEasy to see and understand the test results101 participants
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsI like the overall meter design80 participants
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsMeter is easy to handle90 participants
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsEasy to handle the individual test strips64 participants
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsInstructions (User Guide) easy to understand97 participants
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsInstructions clearly explain how to run a test101 participants
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsInstructions clearly explain meter error message98 participants
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsI found this meter easy to use100 participants
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsI found this meter intuitive96 participants
Intended Users of the Monitoring SystemNumber of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire StatementsI found this meter practical97 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026